MGMT and glioblastoma: Silencing the MGMT gene through promoter methylation has long been known to increase responsiveness to TMZ treatment and improve prognosis in patients with glioblastoma (Karayan-Tapon et al., 2010; Hegi et al., 2005; Esteller et al., 2000).